Antidepressant use and risk of epilepsy and seizures in people aged 20 to 64 years: Cohort study using a primary care database

BMC Psychiatry

Volumn 15, Issue 1, 2015, Pages

  Hill, Trevor ^a   Coupland, Carol ^a   Morriss, Richard ^a   Arthur, Antony ^b   Moore, Michael ^c   Hippisley Cox, Julia ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Antidepressants; Depression; Epilepsy; Primary care database; Seizures; SSRI; Survival analysis; TCA

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; DOSULEPIN; ESCITALOPRAM; FLUOXETINE; LOFEPRAMINE; MIRTAZAPINE; PAROXETINE; SERTRALINE; TRAZODONE; VENLAFAXINE;

ADULT; ARTICLE; COHORT ANALYSIS; DEPRESSION; DISEASE SEVERITY; DRUG SAFETY; DRUG USE; EPILEPSY; FEMALE; HEALTH CARE PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRESCRIPTION; PRIMARY MEDICAL CARE; RISK BENEFIT ANALYSIS; RISK FACTOR; SEIZURE; TREATMENT DURATION; UNITED KINGDOM; CHEMICALLY INDUCED; DEPRESSIVE DISORDER; EPIDEMIOLOGY; FACTUAL DATABASE; PRIMARY HEALTH CARE; STATISTICS AND NUMERICAL DATA;

ADULT; ANTIDEPRESSIVE AGENTS; DATABASES, FACTUAL; DEPRESSIVE DISORDER; EPIDEMIOLOGIC METHODS; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; SEIZURES;

EID: 84950996260     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/s12888-015-0701-9     Document Type: Article

References (34)

1. Moore M, Yuen HM, Dunn N, Mullee MA, Maskell J, Kendrick T. Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database. BMJ. 2009;339:b3999. doi:10.1136/bmj.b3999.
2. Health and Social Care Information Centre. Prescriptions Dispensed in the Community, Statistics for England, 2002-2012. 2013. http://www.hscic.gov. uk/catalogue/PUB11291/pres-disp-com-eng-2002-12-rep.pdf. Accessed 20 Jan 2015.
3. Montgomery SA. Antidepressants and seizures: emphasis on newer agents and clinical implications. Int J Clin Pract. 2005;59(12):1435-40.
4. Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ. 2011;343:d4551. doi:10.1136/bmj. d4551.
5. Choices NHS. Epilepsy. 2014. http://www.nhs.uk/Conditions/Epilepsy/Pages/Introduction.aspx. Accessed 20 Jan 2015.
6. Schmidt D, Schachter SC. Drug treatment of epilepsy in adults. BMJ. 2014; 348:g254. doi:10.1136/bmj.g254.
7. Tellez-Zenteno JF, Patten SB, Jette N, Williams J, Wiebe S. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia. 2007;48(12):2336-44.
8. Hesdorffer DC, Ishihara L, Mynepalli L, Webb DJ, Weil J, Hauser WA. Epilepsy, suicidality, and psychiatric disorders: a bidirectional association. Ann Neurol. 2012;72(2):184-91. http://dx.doi.org/10.1002/ana.23601.
9. Coupland CA, Dhiman P, Barton G, Morriss R, Arthur A, Sach T, et al. A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database. Health Technol Assess. 2011;15(28):1-202. doi:10.3310/hta15280. iii-iv.
10. Coupland C, Morriss R, Arthur A, Moore M, Hill T, Hippisley-Cox J. Safety of antidepressants in adults aged under 65: protocol for a cohort study using a large primary care database. BMC Psychiatry. 2013;13(1):135.
11. Martinez C, Rietbrock S, Wise L, Ashby D, Chick J, Moseley J, et al. Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. BMJ. 2005;330(7488):389.
12. Townsend P, Phillmore P, Beattie A. Health and deprivation: inequality and the North. London: Croom Helm Ltd; 1988.
13. Altman DG. Confidence intervals for the number needed to treat. BMJ. 1998;317(7168):1309-12.
14. Altman DG, Andersen PK. Calculating the number needed to treat for trials where the outcome is time to an event. BMJ. 1999;319(7223):1492-5.
15. Hall GC, Morant SV, Carroll D, Gabriel ZL, McQuay HJ. An observational descriptive study of the epidemiology and treatment of neuropathic pain in a UK general population. BMC Fam Pract. 2013;14:28. http://dx.doi.org/10. 1186/1471-2296-14-28.
16. Hesdorffer DC, Hauser WA, Annegers JF, Cascino G. Major depression is a risk factor for seizures in older adults. Ann Neurol. 2000;47(2):246-9.
17. Hesdorffer DC, Hauser WA, Olafsson E, Ludvigsson P, Kjartansson O. Depression and suicide attempt as risk factors for incident unprovoked seizures. Ann Neurol. 2006;59(1):35-41. doi:10.1002/ana.20685.
18. Pisani F, Oteri G, Costa C, Di Raimondo G, Di Perri R. Effects of psychotropic drugs on seizure threshold. Drug Saf. 2002;25(2):91-110.
19. Jobe PC, Browning RA. The serotonergic and noradrenergic effects of antidepressant drugs are anticonvulsant, not proconvulsant. Epilepsy Behav. 2005;7(4):602-19.
20. Okazaki M, Adachi N, Ito M, Watanabe M, Watanabe Y, Kato M, et al. One-year seizure prognosis in epilepsy patients treated with antidepressants. Epilepsy Behav. 2011;22(2):331-5. http://dx.doi.org/10.1016/j.yebeh.2011.07.016.
21. Melani F, Rosati E, Chiocchetti B, Muscas GC. Antidepressant-associated myoclonic status in a patient with symptomatic generalized epilepsy: does risk occur with therapeutic doses? Epilepsy Behav. 2009;14(4):681-3. http://dx.doi.org/10.1016/j.yebeh.2009.01.018.
22. Cotterman-Hart S. Depression in epilepsy: why aren't we treating? Epilepsy Behav. 2010;19(3):419-21.
23. Gross A, Devinsky O, Westbrook LE, Wharton AH, Alper K. Psychotropic medication use in patients with epilepsy: effect on seizure frequency. J Neuropsychiatry Clin Neurosci. 2000;12(4):458-64.
24. Koster M, Grohmann R, Engel RR, Nitsche MA, Ruther E, Degner D. Seizures during antidepressant treatment in psychiatric inpatients-results from the transnational pharmacovigilance project "Arzneimittelsicherheit in der Psychiatrie" (AMSP) 1993-2008. Psychopharmacology (Berl). 2013;230(2):191-201. http://dx.doi.org/10.1007/s00213-013-3281-8.
25. Cuenca PJ, Holt KR, Hoefle JD. Seizure secondary to citalopram overdose. J Emerg Med. 2004;26(2):177-81.
26. Hayes BD, Klein-Schwartz W, Clark RF, Muller AA, Miloradovich JE. Comparison of toxicity of acute overdoses with citalopram and escitalopram. J Emerg Med. 2010;39(1):44-8.
27. Nemeroff CB. Overview of the safety of citalopram. Psychopharmacol Bull. 2003;37(1):96-121.
28. Alper K, Schwartz KA, Kolts RL, Khan A. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry. 2007;62(4):345-54.
29. Wieseler B, Wolfram N, McGauran N, Kerekes MF, Vervolgyi V, Kohlepp P, et al. Completeness of reporting of patient-relevant clinical trial outcomes: comparison of unpublished clinical study reports with publicly available data. PLoS Med. 2013;10(10):e1001526. doi:10.1371/journal.pmed.1001526.
30. Kumlien E, Lundberg PO. Seizure risk associated with neuroactive drugs: data from the WHO adverse drug reactions database. Seizure. 2010;19(2):69-73.
31. Wang DD, Englot DJ, Garcia PA, Lawton MT, Young WL. Minocycline-and tetracycline-class antibiotics are protective against partial seizures in vivo. Epilepsy Behav. 2012;24(3):314-8. http://dx.doi.org/10.1016/j.yebeh.2012.03.035.
32. Nowak M, Strzelczyk A, Reif PS, Schorlemmer K, Bauer S, Norwood BA, et al. Minocycline as potent anticonvulsant in a patient with astrocytoma and drug resistant epilepsy. Seizure. 2012;21(3):227-8.
33. Mori H, Takahashi K, Mizutani T. Interaction between valproic acid and carbapenem antibiotics. Drug Metab Rev. 2007;39(4):647-57.
34. Abraham J, Fox PD, Condello C, Bartolini A, Koh S. Minocycline attenuates microglia activation and blocks the long-term epileptogenic effects of earlylife seizures. Neurobiol Dis. 2012;46(2):425-30.